Iovance Biotherapeutics, Inc.
IOVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $158,134 | $132,469 | $171,668 | $115,694 |
| Short-Term Investments | $142,669 | $168,714 | $188,045 | $208,087 |
| Receivables | $66,761 | $59,938 | $70,938 | $69,340 |
| Inventory | $51,710 | $49,833 | $65,545 | $51,520 |
| Other Curr. Assets | $9,817 | $11,546 | $16,453 | $12,377 |
| Total Curr. Assets | $429,091 | $422,500 | $512,649 | $457,018 |
| Property Plant & Equip (Net) | $175,413 | $172,422 | $162,487 | $164,282 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $285,208 | $296,253 | $285,356 | $282,398 |
| Long-Term Investments | $5,965 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9,271 | $16,262 | $6,248 | $6,728 |
| Total NC Assets | $475,857 | $484,937 | $454,091 | $453,408 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $904,948 | $907,437 | $966,740 | $910,426 |
| Liabilities | – | – | – | – |
| Payables | $31,237 | $32,004 | $28,489 | $27,509 |
| Short-Term Debt | $7,281 | $8,070 | $9,499 | $12,896 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $87,267 | $89,081 | $84,705 | $81,936 |
| Total Curr. Liab. | $125,785 | $129,155 | $122,693 | $122,341 |
| LT Debt | $45,211 | $45,096 | $44,220 | $45,365 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $31,665 | $34,698 | $31,962 | $32,315 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $76,876 | $79,794 | $76,182 | $77,680 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $45,211 | $52,166 | $52,719 | $57,261 |
| Total Liabilities | $202,661 | $208,949 | $198,875 | $200,021 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $2 | $2 | $3 |
| Common Stock | $16 | $14 | $14 | $13 |
| Retained Earnings | -$2,703,626 | -$2,612,373 | -$2,500,715 | -$2,384,552 |
| AOCI | $16,103 | $20,859 | $6,294 | -$1,046 |
| Other Equity | $3,389,792 | $3,289,986 | $3,262,270 | $3,095,987 |
| Total Equity | $702,287 | $698,488 | $767,865 | $710,405 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $904,948 | $907,437 | $966,740 | $910,426 |
| Net Debt | -$105,642 | -$79,303 | -$117,949 | -$57,433 |